Prothena reported $5.16M in Trade Debtors for its fiscal quarter ending in December of 2023.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 178.32M 11.98M Sep/2026
Agios Pharmaceuticals USD 24.22M 8.08M Jun/2026
Akebia Therapeutics USD 47.03M 19.19M Dec/2025
ALKERMES USD 459.09M 2.61M Sep/2026
Alnylam Pharmaceuticals USD 1.08B 172.17M Sep/2026
Amgen USD 10.35B 126M Sep/2026
Biogen USD 2.38B 15.8M Sep/2026
BioMarin Pharmaceutical USD 1.08B 15.31M Sep/2026
Exelixis USD 328.47M 6.25M Sep/2026
Immunic USD 333K 156K Dec/2025
Incyte USD 1.24B 111.82M Sep/2026
Ionis Pharmaceuticals USD 88M 29.15M Sep/2026
MacroGenics USD 144.17M 133.75M Jun/2026
Nektar Therapeutics USD 3.6M 1.82M Mar/2026
Neurocrine Biosciences USD 957.3M 70.3M Sep/2026
Prothena USD 5.16M 0 Dec/2023
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Ultragenyx Pharmaceutical USD 200M 140M Jun/2026
Vertex Pharmaceuticals USD 2.31B 176.7M Sep/2026